Juan C. Ravell - Concepedia

Author

Juan C. Ravell

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

J Ravell, Juan C Ravell, Juan C. Ravell, Juan Carlos Ravell, Juan Ravell

Publications

630

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health National Human Genome Research Institute National Institutes of Health Clinical Center University of Pennsylvania

About

Juan C. Ravell is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	208
2	Health Sciences	1	1	19
3	Allergy	1	1	99
4	Cell Biology	1	1	14
5	Clinical Nutrition	1	1	19

Juan C. Ravell

Publications

439

Citations

H-Index

Page 1

	Year	Citations
Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease Juan C. Ravell, Mami Matsuda‐Lennikov, Samuel D. Chauvin, Journal of Clinical Investigation X-linked ImmunodeficiencyImmunodeficienciesImmunologyPathologyImmunotherapy	2019	99
Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes Mami Matsuda‐Lennikov, Matthew Biancalana, Juan Zou, Journal of Biological Chemistry	2019	90
Mg2+ regulation of kinase signaling and immune function Chryssa Kanellopoulou, Alex George, Evan Masutani, The Journal of Experimental Medicine	2019	81
Identification of Patients with RAG Mutations Previously Diagnosed with Common Variable Immunodeficiency Disorders David Buchbinder, Rebecca Baker, Yu Nee Lee, Journal of Clinical Immunology Primary ImmunodeficiencyAutoimmune DiseaseMedicineImmunodeficienciesGenetic Epidemiology	2014	76
CRISPR-targeted<i>MAGT1</i>insertion restores XMEN patient hematopoietic stem cells and lymphocytes Julie Brault, Taylor Liu, Ezekiel Bello, Blood	2021	36
A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease Samuel D. Chauvin, Susan Price, Juan Zou, Journal of Clinical Immunology Magnesium SupplementationClinical NutritionXmen DiseasePharmacotherapyCrossover Study	2021	19
Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy Silvia Sánchez‐Ramón, Juan C. Ravell, Inmaculada de la Torre, Rheumatology International	2009	14
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease Julie Brault, Ronald J. Meis, Linhong Li, Cytotherapy Primary ImmunodeficiencyPotential Cell TherapyHuman RetrovirusImmunologyAntiviral Response	2020	14
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway Ann Y. Park, Michael Leney-Greene, Matthew Lynberg, Nature Immunology	2024	10

Page 1